The AHA urged Congressional leaders to support the bipartisan Healthcare Workforce Resilience Act (H.R. 6788/S.3599), and include it in forthcoming COVID-19 relief legislation.
Novel Coronavirus (COVID-19) News
Below are links to AHA Today stories on novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
A bipartisan group of representatives and senators released details on a $908 billion COVID-19 relief bill that they are pushing.
Over 9,000 eligible nursing homes, or 69%, will receive a portion of $523 million in COVID-19 Provider Relief Funds for meeting infection control and mortality criteria in effect from September through October, the Health Resources and Services Administration announced.
The Centers for Medicare & Medicaid Services updated its guidance on enforcement discretion during the COVID-19 public health emergency for laboratories performing molecular and antigen tests for the virus on asymptomatic individuals at the point of care or in patient care settings operating under a Clinical Laboratory Improvement Amendments certificate.
The Department of Health and Human Services has released hospital-level data on COVID-19 capacity, aggregated by week going back to Aug. 1.
The Centers for Medicare & Medicaid Services Dec. 9 at 4 p.m. ET will host a call to discuss recent flexibilities the agency announced to allow acute health care services to be provided outside of a hospital setting in response to the surging COVID-19 pandemic.
New edition of COVID-19 Snapshot paints difficult picture for hospitals scrambling for pandemic help
The AHA released a new edition of the COVID-19 Snapshot to impart upon Congress the critical needs of hospitals and health systems during the deepening public health emergency.
The Food and Drug Administration released a briefing document on Pfizer’s BNT162b2 COVID-19 vaccine candidate that confirms the drug maker’s claims of the vaccine’s efficacy and safety.
The Centers for Disease Control and Prevention has published an addenda with instructions for implementing six new ICD-10 diagnosis codes for reporting COVID-19-related conditions on health care claims effective Jan. 1.
The Food and Drug Administration authorized the first prescription diagnostic test for both COVID-19 and influenza A and B that allows patients to collect a sample at home and ship it to a laboratory for analysis.
Since the COVID-19 pandemic arrived in the U.S. nearly 10 months ago, our hospitals and health systems have learned so much about how to slow down the spread, care for patients and help them recover.
To continue emphasizing the message of protecting against both the flu and COVID-19, AHA’s Wear A Mask and United Against the Flu campaigns released new resources, including new sample social media messages and graphics that hospitals and health systems can use to reiterate the importance of getting a flu shot, wearing a mask and practicing good hygiene.
The AHA released the latest edition of a new report for Congress to better understand the needs of hospitals and health systems during the public health emergency.
The Centers for Medicare & Medicaid Services has identified the Healthcare Common Procedural Coding System codes and Medicare Part B payment allowances effective Nov. 21 for administering casirivimab and imdevimab, a combination monoclonal antibody therapy made by Regeneron.
The Cybersecurity and Infrastructure Security Agency alerted organizations to a global phishing and spearphishing campaign targeting the COVID-19 vaccine cold chain, the part of the supply chain used to store and transport a vaccine at safe temperatures.
The Department of Health and Human Services amended its declaration under the Public Readiness and Emergency Preparedness Act to expand access to COVID-19 medical countermeasures through telehealth and clarify the scope of liability protections.
Two hundred twenty-four. That’s the number of days since the last COVID-19 relief package was signed into law.
The AHA recently joined a non-partisan coalition, Get Covered 2021, to promote tools to stop the spread of COVID-19 and expand health coverage to millions of uninsured Americans. Molly Smith, AHA vice president of coverage and state issues forum, explains how hospitals and health systems can get involved in this meaningful effort to improve the overall health of individuals and communities.
The FDA this week revised and reissued its August emergency use authorization for COVID-19 convalescent plasma to treat hospitalized patients with COVID-19. The revised EUA adds the Mount Sinai COVID-19 ELISA IgG Antibody Test as an acceptable test for qualifying high and low titer COVID-19 convalescent plasma.
The Centers for Disease Control and Prevention announced shorter quarantine options based on local circumstances and resources, for people exposed to the COVID-19 virus.